Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1150081

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1150081

Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By End-Use (Hospitals, Orthopedic Clinics, Ambulatory Care Centers, Research & Academic Institutes, Others); By Product; By Application; By Region; Segment Forecast, 2022 - 2030

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global orthobiologics market size is expected to reach USD 11.77 billion by 2030, according to a new study by Polaris Market Research. The report "Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By Product (Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, and Others); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased use of platelet-rich plasma, homologous conditioned plasma, and adipose-generated stromal cell treatment is also predicted to contribute to market expansion. Orthobiologics, which are most usually connected with sports injuries, are organic substances, including platelet-rich plasma (PRP) or stem cells, that are used to accelerate the recovery process for musculoskeletal problems.

They can be used alone as well as in conjunction with traditional pharmacological and non-pharmaceutical therapy options. Orthobiologic therapies, in particular, consider introducing large concentrations of natural sources of cellular ingredients to an injury site to accelerate the recovery process of muscles, ligaments, soft tissue, joints, and other organs, thereby reducing recovery time and due to injuries pain, and swelling.

Further, the development in the occurrence of sports injuries and road accidents is likely to drive the growth of the market during the forecast period. As per the John Hopkins Medicines, in the United States, about 30 million children and teenagers participate in some type of sports, and every year, around 3.5 million injuries occur, which results in some loss of engagement time.

Thus, orthobiologic therapies are utilized in sports medicine to treat either acute or chronic disorders, including typical overuse injuries. Athletes and orthopedists frequently turn to orthobiologic therapy to quickly recover an athlete to the pre-injury physical state. Most orthopedists will try to employ biologics instead of medications and/or intrusive surgery.

Furthermore, the rise in the prevalence of spinal illnesses and disorders is expected to fuel the expansion of the market. For instance, as per the National Spinal Cord Injury Statistical Center, the average annual incidence of SCI is around 54 instances per one million individuals, or approximately 17,810 additional SCI cases each year.

As per the WHO, every year, approximately 250 000 and 500 000 people worldwide develop a spinal cord injury (SCI). Most spinal cord accidents are caused by avoidable causes such as car accidents and falls. Therefore, the rising prevalence of sports injuries along with spinal disorders are the factors that are boosting the demand for orthobiologics therapy or treatment and are driving the market growth.

Orthobiologics Market Report Highlights

The soft tissue injuries segment is anticipated to grow at the fastest CAGR over the forecast period owing to a rise in sports-related injuries and the desire for orthobiologics for cartilage regeneration.

Spinal fusion segment accounted for a significant share of the global revenue due to the rising use of artificial matrices and allografts in spine fusion surgeries.

Asia Pacific is expected to witness substantial growth over the projected period. This is growing owing to increased healthcare spending, rising disposable personal wealth, and an increase in road traffic accidents in various nations. The public funding for health education and services is also rising.

The global players include Alphatec Spine Incorporation, DePuy Synthes, Incorporation, Exactech, Inc., Globus Medical, Inc., Globus Medical, Inc., Harvest Technologies Corporation, Orthofix Holdings, Inc., Stryker Corporation, SeaSpine Holdings Corporation, Wright Medical Group N.V., and Zimmer Biomet, Inc.

Polaris Market Research has segmented the Orthobiologics market report based on product, application, end-use, and region:

Orthobiologics, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Demineralized Bone Matrix(DBM)

Allograft

Bone Morphogenetic Protein (BMP)

Viscosupplementation

Synthetic Bone Substitutes

Stem Cell Therapy

Others

Orthobiologics, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Spinal Fusion

Trauma Repair

Osteoarthritis and Degenerative Arthritis

Soft Tissue Injuries

Maxillofacial and Dental Applications

Reconstructive Surgery

Orthobiologics, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Orthopedic Clinics

Ambulatory Care Centers

Research and Academic Institutes

Others

Orthobiologics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Product Code: PM1394

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Orthobiologics Market Insights

  • 4.1. Orthobiologics - Industry Snapshot
  • 4.2. Orthobiologics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growth in aging population
      • 4.2.1.2. Increase in sports injuries
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of orthobiologics product
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Orthobiologics Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Orthobiologics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 5.3. Demineralized Bone Matrix(DBM)
    • 5.3.1. Global Orthobiologics Market, by Demineralized Bone Matrix(DBM), by Region, 2018 - 2030 (USD Billion)
  • 5.4. Allograft
    • 5.4.1. Global Orthobiologics Market, by Allograft, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Bone Morphogenetic Protein (BMP)
    • 5.5.1. Global Orthobiologics Market, by Bone Morphogenetic Protein (BMP), by Region, 2018 - 2030 (USD Billion)
  • 5.6. Viscosupplementation
    • 5.6.1. Global Orthobiologics Market, by Viscosupplementation, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Synthetic Bone Substitutes
    • 5.7.1. Global Orthobiologics Market, by Synthetic Bone Substitutes, by Region, 2018 - 2030 (USD Billion)
  • 5.8. Stem Cell Therapy
    • 5.8.1. Global Orthobiologics Market, by Stem Cell Therapy, by Region, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Other Orthobiologics Market, by Region, 2018 - 2030 (USD Billion)

6. Global Orthobiologics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 6.3. Spinal Fusion
    • 6.3.1. Global Orthobiologics Market, by Spinal Fusion, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Trauma Repair
    • 6.4.1. Global Orthobiologics Market, by Trauma Repair, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Osteoarthritis and Degenerative Arthritis
    • 6.5.1. Global Orthobiologics Market, by Osteoarthritis and Degenerative Arthritis, by Region, 2018 - 2030 (USD Billion)
  • 6.6. Soft Tissue Injuries
    • 6.6.1. Global Orthobiologics Market, by Soft Tissue Injuries, by Region, 2018 - 2030 (USD Billion)
  • 6.7. Maxillofacial and Dental Applications
    • 6.7.1. Global Orthobiologics Market, by Maxillofacial and Dental Applications, by Region, 2018 - 2030 (USD Billion)
  • 6.8. Reconstructive Surgery
    • 6.8.1. Global Orthobiologics Market, by Reconstructive Surgery, by Region, 2018 - 2030 (USD Billion)

7. Global Orthobiologics Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Orthobiologics Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Orthopedic Clinics
    • 7.4.1. Global Orthobiologics Market, by Orthopedic Clinics, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Ambulatory Care Centers
    • 7.5.1. Global Orthobiologics Market, by Ambulatory Care Centers, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Research and Academic Institutes
    • 7.6.1. Global Orthobiologics Market, by Research and Academic Institutes, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Other Orthobiologics Market, by Region, 2018 - 2030 (USD Billion)

8. Global Orthobiologics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Orthobiologics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Orthobiologics Market - North America
    • 8.3.1. North America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.3.4. Orthobiologics Market - U.S.
      • 8.3.4.1. U.S.: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.3.5. Orthobiologics Market - Canada
      • 8.3.5.1. Canada: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4. Orthobiologics Market - Europe
    • 8.4.1. Europe: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.4. Orthobiologics Market - UK
      • 8.4.4.1. UK: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.5. Orthobiologics Market - France
      • 8.4.5.1. France: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.6. Orthobiologics Market - Germany
      • 8.4.6.1. Germany: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.7. Orthobiologics Market - Italy
      • 8.4.7.1. Italy: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.8. Orthobiologics Market - Spain
      • 8.4.8.1. Spain: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.9. Orthobiologics Market - Netherlands
      • 8.4.9.1. Netherlands: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.10. Orthobiologics Market - Russia
      • 8.4.10.1. Russia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Russia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Russia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5. Orthobiologics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.4. Orthobiologics Market - China
      • 8.5.4.1. China: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.5. Orthobiologics Market - India
      • 8.5.5.1. India: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.6. Orthobiologics Market - Malaysia
      • 8.5.6.1. Malaysia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.7. Orthobiologics Market - Japan
      • 8.5.7.1. Japan: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.8. Orthobiologics Market - Indonesia
      • 8.5.8.1. Indonesia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.9. Orthobiologics Market - South Korea
      • 8.5.9.1. South Korea: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6. Orthobiologics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.4. Orthobiologics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.5. Orthobiologics Market - UAE
      • 8.6.5.1. UAE: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.6. Orthobiologics Market - Israel
      • 8.6.6.1. Israel: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.7. Orthobiologics Market - South Africa
      • 8.6.7.1. South Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.7. Orthobiologics Market - Latin America
    • 8.7.1. Latin America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.4. Orthobiologics Market - Mexico
      • 8.7.4.1. Mexico: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.5. Orthobiologics Market - Brazil
      • 8.7.5.1. Brazil: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.6. Orthobiologics Market - Argentina
      • 8.7.6.1. Argentina: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Alphatec Spine Incorporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Arthrex Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bone Biologics Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bacterin International Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DePuy Synthes, Incorporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Exactech, Inc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Genzyme Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Globus Medical, Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Globus Medical, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Harvest Technologies Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Integra Lifesciences Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Medtronic, Plc
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. NuVasive, Incorporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Orthofix Holdings, Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Ortho Regenerative Technologies Inc
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Stryker Corporation
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. SeaSpine Holdings Corporation
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Wright Medical Group N.V
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
  • 10.19. Zimmer Biomet, Inc
    • 10.19.1. Company Overview
    • 10.19.2. Financial Performance
    • 10.19.3. Product Benchmarking
    • 10.19.4. Recent Development
Product Code: PM1394

List of Tables

  • Table 1 Global Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 2 Global Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 3 Global Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 4 Orthobiologics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 5 North America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 6 North America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 7 North America: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 8 U.S.: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 9 U.S.: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 11 Canada: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 12 Canada: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 13 Canada: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 14 Europe: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 15 Europe: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 16 Europe: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 17 UK: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 18 UK: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 19 UK: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 20 France: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 21 France: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 22 France: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 26 Italy: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 27 Italy: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 28 Italy: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 29 Spain: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 30 Spain: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 31 Spain: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 32 Netherlands: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 33 Netherlands: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 34 Netherlands: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 35 Russia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 36 Russia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 37 Russia: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 41 China: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 42 China: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 43 China: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 44 India: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 45 India: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 46 India: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 47 Malaysia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 48 Malaysia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 49 Malaysia: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 50 Japan: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 51 Japan: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 52 Japan: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 53 Indonesia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 54 Indonesia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 55 Indonesia: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 56 South Korea: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 57 South Korea: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 58 South Korea: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 64 Saudi Arabia: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 65 UAE: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 66 UAE: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 67 UAE: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 68 Israel: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 69 Israel: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 70 Israel: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 71 South Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 72 South Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 73 South Africa: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 74 Latin America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 75 Latin America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 76 Latin America: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 77 Mexico: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 78 Mexico: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 79 Mexico: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 80 Brazil: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 81 Brazil: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 83 Argentina: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • Table 84 Argentina: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • Table 85 Argentina: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Orthobiologics Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Application

Figure 7. Global Orthobiologics Market, by Application, 2021 & 2030 (USD Billion)

Figure 8. Market by Product

Figure 9. Global Orthobiologics Market, by Product, 2021 & 2030 (USD Billion)

Figure 10. Market by End-Use

Figure 11. Global Orthobiologics Market, by End-Use, 2021 & 2030 (USD Billion)

Figure 12. Orthobiologics Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 13. Strategic Analysis - Orthobiologics Market

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!